Trader consensus strongly backs no new coronavirus pandemic in 2026, with 94% market-implied odds, anchored by robust population immunity from billions of prior SARS-CoV-2 infections and booster vaccines, plus global surveillance networks like GISAID tracking variants in real time. Health agencies report current strains, such as KP.3.1.1, sparking only mild seasonal upticks controllable via antivirals and wastewater monitoring. Historical data underscores pandemics' rarity—major coronavirus events decades apart. Realistic challenges include a novel zoonotic spillover from bats or rodents, or an immune-escape variant surging unexpectedly, though models peg these risks low absent early signals.